KLRK1 and metabolic dysfunction-associated steatotic liver disease: However, the effect of this subtype has not yet been reported, and unlike in NAFLD and atherosclerosis, which are discussed below, obesity-induced inflammation and insulin resistance development seem to exhibit an absence of the NKG2D-NKG2D ligand interaction in ATMs (33).